299 related articles for article (PubMed ID: 24082367)
1. Mechanisms of chronic cardiac allograft rejection.
Costello JP; Mohanakumar T; Nath DS
Tex Heart Inst J; 2013; 40(4):395-9. PubMed ID: 24082367
[TBL] [Abstract][Full Text] [Related]
2. Immunology insights into cardiac allograft rejection.
Savasta M; Lentini S
Rev Cardiovasc Med; 2011; 12(2):e68-76. PubMed ID: 21796085
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments.
Suzuki J; Isobe M; Morishita R; Nagai R
Circ J; 2010 Feb; 74(2):233-9. PubMed ID: 20009354
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity and cardiac allograft rejection.
Millington TM; Madsen JC
Kidney Int Suppl; 2010 Dec; (119):S18-21. PubMed ID: 21116311
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Allograft Vasculopathy: The Enduring Enemy of Cardiac Transplantation.
Nikolova AP; Kobashigawa JA
Transplantation; 2019 Jul; 103(7):1338-1348. PubMed ID: 31241553
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 Antagonist Reduced the Incidence of Acute Rejection and Controlled Cardiac Allograft Vasculopathy in a Swine Heart Transplant Model Receiving a Mycophenolate-based Immunosuppressive Regimen.
Hsu WT; Lin CH; Jui HY; Tseng YH; Shun CT; Hsu MC; Wu KK; Lee CM
Transplantation; 2018 Dec; 102(12):2002-2011. PubMed ID: 30095739
[TBL] [Abstract][Full Text] [Related]
8. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
9. Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft.
Bogossian H; Frommeyer G; Ninios I; Bandorski D; Seyfarth M; Matzaroglou C; Lemke B; Eckardt L; Zarse M; Kafchitsas K
Cardiovasc Ther; 2016 Aug; 34(4):183-90. PubMed ID: 26924260
[TBL] [Abstract][Full Text] [Related]
10. New Targets for the Prevention of Chronic Rejection after Thoracic Organ Transplantation.
Heim C; Gocht A; Weyand M; Ensminger S
Thorac Cardiovasc Surg; 2018 Jan; 66(1):20-30. PubMed ID: 29258125
[TBL] [Abstract][Full Text] [Related]
11. Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys.
Azimzadeh AM; Zhang T; Wu G; Kelishadi SS; Stoddard T; OʼNeill N; Nguyen BN; Welty E; Avon C; Higuchi M; Mitchell SL; Hershfeld A; Cheng XF; Kronfli A; Rybak E; Burdorf L; Pierson RN
Transplantation; 2017 Jan; 101(1):63-73. PubMed ID: 27362307
[TBL] [Abstract][Full Text] [Related]
12. Predicting the development of cardiac allograft vasculopathy.
Seki A; Fishbein MC
Cardiovasc Pathol; 2014; 23(5):253-60. PubMed ID: 24972526
[TBL] [Abstract][Full Text] [Related]
13. Tanshinol suppresses cardiac allograft rejection in a murine model.
Lu C; Zeng YQ; Liu H; Xie Q; Xu S; Tu K; Dou C; Dai Z
J Heart Lung Transplant; 2017 Feb; 36(2):227-236. PubMed ID: 27574736
[TBL] [Abstract][Full Text] [Related]
14. Intrapatient Variability in Tacrolimus Exposure Does Not Predict The Development of Cardiac Allograft Vasculopathy After Heart Transplant.
Shuker N; Bouamar R; Hesselink DA; van Gelder T; Caliskan K; Manintveld OC; Balk AH; Constantinescu AA
Exp Clin Transplant; 2018 Jun; 16(3):326-332. PubMed ID: 28969528
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy-related human leukocyte antigen sensitization leading to cardiac allograft vasculopathy and graft failure in a heart transplant recipient: a case report.
Ginwalla M; Pando MJ; Khush KK
Transplant Proc; 2013 Mar; 45(2):800-2. PubMed ID: 23498823
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients.
Vrtovec B; Haddad F; Pham M; Deuse T; Fearon WF; Schrepfer S; Leon S; Vu T; Valantine H; Hunt SA
Transplant Proc; 2013; 45(6):2406-9. PubMed ID: 23953556
[TBL] [Abstract][Full Text] [Related]
17. Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.
OʼNeill NA; Zhang T; Braileanu G; Sun W; Cheng X; Hershfeld A; Laird CT; Kronfli A; Hock LA; Dahi S; Kubicki N; Sievert E; Hassanein W; Cimeno A; Pierson RN; Azimzadeh AM
Transplantation; 2017 Sep; 101(9):2038-2047. PubMed ID: 28557955
[TBL] [Abstract][Full Text] [Related]
18. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
[TBL] [Abstract][Full Text] [Related]
19. Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients.
Arora S; Andreassen AK; Karason K; Gustafsson F; Eiskjær H; Bøtker HE; Rådegran G; Gude E; Ioanes D; Solbu D; Dellgren G; Ueland T; Aukrust P; Gullestad L;
Circ Heart Fail; 2018 Sep; 11(9):e004050. PubMed ID: 30354362
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: the effect of augmentation of donor antigen load.
Yamada K; Mawulawde K; Menard MT; Shimizu A; Aretz HT; Choo JK; Allison KS; Slisz JK; Sachs DH; Madsen JC
J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):709-19. PubMed ID: 10733759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
